role
massbiolog
compar
tradit
drug
compani
research
focus
monoclon
antibodi
pick
primarili
infecti
diseas
unmet
medic
although
nt
big
market
still
repres
signific
public
health
need
role
take
technolog
take
great
scienc
target
diseas
market
matter
mayb
nt
larg
enough
compani
field
interest
give
exampl
massbiolog
step
privat
compani
nt
involv
respons
sar
sever
acut
respiratori
syndrom
outbreak
good
exampl
agent
discov
monoclon
antibodi
show
work
anim
less
year
spent
energi
develop
antibodi
get
readi
diseas
went
heaven
total
pleas
howev
got
antibodi
ever
return
institut
copi
massbiolog
model
uniqu
histori
sure
histori
copi
histori
licens
product
manufactur
research
facil
fund
royalti
stream
put
togeth
go
unmet
medic
need
duplic
place
hard
start
middl
choos
leav
academ
clinic
posit
lead
massbiolog
appeal
idea
one
could
marshal
capabl
full
spectrum
product
develop
basic
discoveri
clinic
studi
hope
approv
medicin
want
actual
take
idea
product
see
work
patient
done
thrill
moreov
want
unmet
medic
need
uniqu
part
abl
choos
target
import
public
health
unit
state
develop
world
might
enough
market
interest
big
pharma
biotech
actual
develop
product
uniqu
public
nonprofit
entiti
centuri
incept
massbiolog
still
fund
state
self
fund
two
gener
sourc
revenu
manufactur
sell
tetanu
diphtheria
vaccin
royalti
incom
past
invent
product
call
cytogam
licens
csl
behr
immun
globulin
isol
human
blood
product
cytomegaloviru
infect
associ
diseas
organ
transplant
newer
product
call
synagi
manufactur
astrazeneca
medimmun
monoclon
antibodi
protect
babi
respiratori
syncyti
viru
newer
royalti
stream
experiment
clostridium
difficil
product
licens
merck
massbiolog
transfer
state
health
depart
univers
massachusett
medic
school
impact
transit
made
import
posit
step
lab
product
develop
think
partner
collabor
public
health
depart
medic
school
got
great
scientist
collabor
infrastructur
allow
us
take
success
model
move
forward
new
era
allow
us
build
new
facil
make
discoveri
intellectu
properti
system
patent
discoveri
collabor
public
entiti
pharma
structur
allow
oper
grow
around
employe
also
give
medic
school
student
opportun
train
lab
particip
develop
clinic
trial
favorit
project
develop
watch
nt
think
wise
pet
project
heart
rabi
trial
work
collabor
serum
institut
india
impact
believ
monoclon
antibodi
rabi
viru
avail
would
nt
avail
nt
us
submit
trial
regulatori
agenc
india
hope
hundr
patient
enrol
start
nt
take
mani
month
complet
expect
licensur
licens
sold
also
becom
avail
countri
